USA - NYSE:KB - US48241A1051 - ADR
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 41.19T | 38.55T | 38.56T | 41.10T | 38.97T | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 13.01T | 12.83T | 12.18T | 11.52T | 11.23T | |||
| Non Interest Income | 28.18T | 25.72T | 26.38T | 29.59T | 27.74T | |||
| Loan Loss Provision | 2.24T | 2.04T | 3.15T | 1.85T | 1.19T | |||
| Net Interest Income after Provision | 10.77T | 10.78T | 9.03T | 9.67T | 10.04T | |||
| Non Interest Expense | -31.11T | -29.52T | -29.29T | -33.81T | -31.70T | |||
| Minority Interest Expense | 44.05B | 49.62B | 68.50B | 221.59B | 25.16B | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 7.84T | 6.99T | 6.12T | 5.45T | 6.08T | |||
| Income Tax | 2.07T | 1.96T | 1.59T | 1.52T | 1.70T | |||
| Net Income | 5.65T | 4.88T | 4.41T | 4.03T | 4.34T | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 15.85K | 13.34K | 11.75K | 10.58K | 11.40K | |||
| Non GAAP EPS | 15.83K | 13.37K | 11.92K | 11.23K | 11.43K | |||
| Statistics | ||||||||
| Profit Margin | 13.72% | 12.66% | 11.44% | 9.80% | 11.13% | |||
All data in KRW